<DOC>
	<DOCNO>NCT02486614</DOCNO>
	<brief_summary>The aim study evaluate effect regional citrate anti-coagulation different pathway coagulation system critically ill patient acute kidney injury . This form basis future study investigator plan focus patient premature circuit clot despite optimal post-filtrate ionised calcium parameter .</brief_summary>
	<brief_title>Effect Citrate Coagulation System Patients Receiving CRRT</brief_title>
	<detailed_description>Purpose clinical trial : To evaluate effect regional citrate anti-coagulation different pathway coagulation system critically ill patient acute kidney injury . Patient population : critically ill patient acute kidney injury require citrate-based continuous renal replacement therapy ( CRRT ) Primary objective : Changes baseline number measure coagulability ( platelet count ; Prothrombin Time ; Activated Partial Thromboplastin Time ratio ; fibrinogen ; d-dimers ; Thrombin generation assay ; Clot lysis ; platelet function analysis 100 ) blood within patient 's systemic circulation CRRT circuit course 72 hour regional anticoagulation citrate . Number Subjects/Patients : 12 patient complete data . Trial Design : Prospective non-interventional study . Endpoints : Change baseline number measure coagulability . Main Inclusion Criteria : Adult intensive care patient undergo CRRT citrate regional anti-coagulation AKI .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Inclusion criterion : acute kidney injury treat citrate base continuous renal replacement therapy ( CRRT ) age &gt; 18 year . expect require &gt; 72 hour CRRT . Exclusion criterion : Known preexist clotting tendency Known preexist bleeding tendency Disseminated Intravascular Coagulation ( DIC ) Prior transfusion blood product 24 hour enrolment Active bleeding ( ie . need blood transfusion ) time enrolment Haemoglobin time enrolment &lt; 75g/L Haematocrit time enrolment &gt; 0.55 Patient would refuse Red Blood Cell transfusion ( example Jehova 's Witness ) . Platelet count time enrolment &lt; 100x103/ÂµL Treatment anticoagulant antiplatelet agent time enrolment within 7 day enrolment exception heparin low molecular weight heparin DVT prophylaxis . Intravenous heparin exposure within 4 hour commence citrate anticoagulation . Malnourished : BMI &lt; 18.5kg/m2 unplanned weight loss &gt; 10 % actual body weight ( ABW ) precede 6 month BMI &lt; 20kg/m2 unplanned weight loss &gt; 5 % ABW precede 6 month . CRRT prescribed indication AKI ( example poisoning ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>